Items where authors include "Siddiqui, E."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 4.

Article

Herschorn, S., Chapple, C.R. orcid.org/0000-0002-2960-9931, Snijder, R. et al. (2 more authors) (2017) Could Reduced Fluid Intake Cause the Placebo Effect Seen in Overactive Bladder Clinical Trials? Analysis of a Large Solifenacin Integrated Database. Urology, 106. pp. 55-59. ISSN 0090-4295

Drake, M.J., MacDiarmid, S., Chapple, C.R. orcid.org/0000-0002-2960-9931 et al. (8 more authors) (2017) Cardiovascular safety in refractory incontinent patients with overactive bladder receiving add-on mirabegron therapy to solifenacin (BESIDE). International Journal of Clinical Practice, 71 (5). e12944 . ISSN 1368-5031

Chapple, C.R. orcid.org/0000-0002-2960-9931, Nazir, J., Hakimi, Z. et al. (6 more authors) (2017) Persistence and Adherence with Mirabegron versus Antimuscarinic Agents in Patients with Overactive Bladder: A Retrospective Observational Study in UK Clinical Practice. European Urology. ISSN 0302-2838

Chapple, C.R. orcid.org/0000-0002-2960-9931, Nitti, V.W., Khullar, V. et al. (5 more authors) (2014) Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World Journal of Urology, 32 (6). pp. 1565-1572. ISSN 0724-4983

This list was generated on Sun Mar 24 18:48:33 2024 GMT.